Welcome to our dedicated page for Altria Group news (Ticker: MO), a resource for investors and traders seeking the latest updates and insights on Altria Group stock.
Altria Group, Inc. (MO) generates a steady flow of news through its financial results, product updates, capital allocation decisions and corporate governance actions. As a U.S. tobacco manufacturing company with both combustible and smoke-free products, Altria regularly issues press releases and files current reports that provide insight into its operations, portfolio and strategic direction.
Investors following MO news can expect detailed earnings announcements covering quarterly and year-to-date performance, including net revenues, earnings per share metrics and commentary on segment trends in smokeable and oral tobacco products. These releases often discuss factors affecting results, such as pricing, volume, special items, and the performance of brands like on! within the oral tobacco segment.
Altria’s news flow also highlights capital returns and financing activity. The company frequently announces regular quarterly dividends and dividend increases, as well as share repurchase activity and changes to its share repurchase program authorization. In addition, it discloses debt offerings and related agreements through press releases and Form 8-K filings, outlining new senior unsecured notes and credit facility amendments.
Corporate and strategic developments are another key news category. Altria reports on leadership and Board changes, including CEO succession plans, future appointments to executive roles and the planned retirement of directors. It also issues updates on its smoke-free strategy, such as product launches in oral nicotine pouches, regulatory submissions for heated tobacco sticks and collaboration agreements, including its memorandum of understanding with KT&G Corporation for modern oral and non-nicotine opportunities.
This MO news page helps readers track these disclosures in one place, from dividend declarations and webcast announcements to strategic partnerships and regulatory milestones. Regular review of Altria’s news can provide context for the company’s financial performance, portfolio evolution and governance decisions.
Altria Group (NYSE: MO) has announced it will host a live audio webcast on July 31, 2024, at 9:00 a.m. Eastern Time to discuss its 2024 second-quarter and first-half business results. The company will release a press release with the results at approximately 7:00 a.m. Eastern Time on the same day. CEO Billy Gifford and CFO Sal Mancuso will lead the discussion and answer questions from investors and media. The webcast will be in listen-only mode and requires pre-event registration. An archived version will be available on Altria's website after the event.
Altria Group announced the submission of Premarket Tobacco Product Applications (PMTAs) to the FDA for its new on! PLUS oral nicotine pouches. Developed by Helix Innovations, these pouches are made from a proprietary soft-feel material for a more comfortable user experience. On! PLUS pouches, designed for adult dippers and dual users, come in tobacco, mint, and wintergreen flavors with three nicotine strength options. Altria believes the product will significantly contribute to Helix's growth upon FDA authorization. In Q1 2024, on! pouches saw a 32% increase in shipment volume and captured a 7.1% market share in the U.S. oral tobacco category.
Altria Group, Inc. (NYSE: MO) announced that the FDA has granted marketing orders for NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%, NJOY DAILY Menthol 4.5%, and NJOY DAILY Extra Menthol 6%. These are the first FDA-authorized menthol e-vapor products, following NJOY's PMTA submission in March 2020.
Altria's CEO, Billy Gifford, emphasized the company's commitment to transitioning adult smokers to less harmful alternatives. NJOY products are now available in over 80,000 stores, with plans to expand to 100,000 by year-end.
However, Altria is obligated to make an additional $250 million payment due to the FDA's issuance of these marketing orders, per the merger agreement. NJOY also submitted a supplemental PMTA for its new ACE 2.0 device, which includes technology to prevent underage use.
NJOY, an Altria company, has submitted a Premarket Tobacco Product Application (PMTA) to the FDA for its NJOY ACE 2.0 device, which incorporates Bluetooth®-enabled access restriction to prevent underage use. The company also re-submitted applications for Blueberry and Watermelon pods compatible with NJOY ACE 2.0. Already the sole FDA-authorized pod-based e-vapor product, the NJOY ACE expanded its distribution to over 80,000 stores in Q1 2024, aiming for 100,000 by year-end. Altria's vision is to transition smokers to smoke-free options responsibly. NJOY aims to address previous FDA concerns regarding underage access and hopes for expedited review and authorization.
Altria Group (NYSE: MO) held its 2024 Annual Meeting of Shareholders, during which CEO Billy Gifford provided remarks and addressed shareholder questions. Preliminary voting results showed the election of 10 Board nominees, the ratification of PricewaterhouseCoopers LLP as independent public accountants for 2024, and the approval of executive compensation on an advisory basis. Two shareholder proposals were not approved. Following the meeting, Altria declared a regular quarterly dividend of $0.98 per share, payable on July 10, 2024, to shareholders of record as of June 14, 2024, with the ex-dividend date also on June 14, 2024. The company continues to focus on transitioning adult smokers to smoke-free products and holds various equity investments, including in Anheuser-Busch InBev and Cronos Group.
Altria Group, Inc. will host a virtual 2024 Annual Meeting of Shareholders on May 16, 2024, where shareholders can vote their shares electronically and submit questions. Non-shareholders can listen as guests but cannot vote or ask questions. The company encourages reviewing business and financial resources and corporate responsibility reports available on their website prior to the meeting.
Summary not available.
Summary not available.
Summary not available.
Summary not available.